Source: Markets Insider

twoXAR: twoXAR Pharmaceuticals Presents Preclinical Data Showing Significant Efficacy and Safety of Two Novel Chronic Kidney Disease Treatment Candidates

PALO ALTO, Calif., March 4, 2021 /PRNewswire/ -- twoXAR Pharmaceuticals, a drug discovery and development company focused on bringing first-in-cla...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew A. Radin's photo - Co-Founder & CEO of twoXAR

Co-Founder & CEO

Andrew A. Radin

CEO Approval Rating

81/100

Read more